Stanford University
Showing 2,541-2,560 of 13,041 Results
-
Niki DeGeorge
Associate Director of Radiation Physics, Radiation Oncology
Current Role at StanfordNiki is the Associate Director of Radiation Physics in the Department of Radiation Oncology.
-
Seena Dehkharghani MD FAHA
Clinical Professor, Radiology
BioMy research spans human, animal, and phantom studies of cerebral perfusion and metabolism, emphasizing thermometry and
neuroenergetics. My investigations into ischemic thermometry were twice recognized with the Foundation of the ASNR Scholar Award in Neuroradiology Research and subsequently by a R01 awarded by the NIBIB. My group has developed novel computational models for cerebral hemodynamics (dynamic BOLD-CVR) and first-of-kind hyperportable microwave stroke detection tools using deep learning. I have obtained formal certification (Mathworks, Google) in machine learning and data analytics and remain engaged in self-learning in AI/ML methodologies. I have also been a post-graduate student through the Stanford University School of Engineering SCPD program in Computer Science, again with a focus in artificial intelligence through the Stanford University School of Engineering, with core competencies including machine learning, Bayesian Networks, Markov Decision Processes, and Deep Learning.
I formerly served as Director of Stroke and Cerebrovacular Imaging Programs at Emory University and New York University, leading basic, translational, and clinical cerebrovascular imaging programs in collaboration with academic and industry partners worldwide. I returned to Stanford in Feb 2025 as Professor and Associate Chair of Informatics, and as Affiliate Faculty of the Wu Tsai Neuroscience Institute, Stanford Artificial Intelligence in Medicine and Imaging (AIMI) Center, Center for Digital Health (CDH), and
Human-Centered AI (HAI) Institute.
Ongoing projects that I would like to highlight include:
1R01EB034820-01 (NIBIB).
Previously, I was funded in an application to the Google AI Social Impact Challenge for the development of portable ultra-wideband microwave imaging instrumentation (patents issued), work for which I was selected to the NIH-NIBIB c3i Concept to Clinic: Commercializing Innovation Program.
Presently, we have proposed to develop realistic computational models of ischemic stroke and bridge a heretofore unattempted multiscale and
multiphysics view of neuroenergetic disturbance in the ischemic brain. The merger of a state of the art in silico neurobiological canvas
with more than a decade of insights from rigorous experimental neuroscience and biophysical modeling points us to disturbed
thermoregulation/dysthermia at the critical intersection of cerebral perfusion, metabolism, viability, and hence neuroenergetic balance.
Cerebral dysthermia will be formalized in a radical departure from the historically perfusion-centered frame of reference in
cerebrovascular ischemia, the latter having shown unfit to capture fully the adaptive, dynamic metabolic changes that subserve the
ischemic brain. We leverage the pathoanatomic realism of our complete multiscale vascular, flow, and perfusion model tuned to direct
measures of cerebral perfusion, oximetry, and thermography across hemodynamics states in individuals subjected to hemodynamics
provocation, linking two procedures developed by my lab: time-resolved BOLD cerebrovascular reactivity with acetazolamide and the
brain thermal response (BTR). This work represents a new direction of cerebrovascular and
neurometabolic research enabled by traditionally unattainable biomarker ensembles based in non-invasive, spatiotemporally-resolved
brain thermography. -
Karl Deisseroth
D. H. Chen Professor, Professor of Bioengineering and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsKarl Deisseroth's laboratory created and developed optogenetics, hydrogel-tissue chemistry (beginning with CLARITY), and a broad range of enabling methods. He also has employed his technologies to discover the neural cell types and connections that cause adaptive and maladaptive behaviors.
-
Cornelia L. Dekker, M.D.
Professor (Research) of Pediatrics (Infectious Diseases), Emerita
Current Research and Scholarly InterestsThe Stanford-LPCH Vaccine Program provides an infrastructure for conducting clinical studies of vaccines in children and adults. We conduct immunology studies of seasonal influenza vaccines in twins, in a longitudinal cohort of young and elderly adults and studies of various vaccine candidates for NIH and industry. Additionally, we were a CDC Clinical Immunization Safety Assessment site for 10 years working on safety issues concerning licensed vaccines.
-
Tina M. Del Cont
Product & Program Manager, Stanford Profiles, Technology & Digital Solutions
Current Role at StanfordI am the Product Manager for Stanford Profiles and Project Manager of the Stanford Profiles University-Wide Project. I work directly with the Stanford Profiles development team in Stanford Medicine | Technology & Digital Solutions Application Development. On this project, I also work with a university-wide project team, the Stanford Profiles (formerly CAP) Working Group, made up of members from many of the Stanford schools and organizations. In June of 2014, we started the CAP Drupal Module Working Group. The purpose of this group is to review and improve the integration process with CAP by expanding and enhancing the CAP Drupal Module (CAPx) with an open-source contribution approach (an initiative started and led by SWS in collaboration with the CAP Drupal Module user community).
If you are interested in becoming part of the Stanford Profiles University-Wide Project, which includes the Stanford Profiles Public and Stanford-only View web sites or would like more information on integrating your web site with Stanford Profiles, contact me at tdelcont@stanford.edu. -
Claudia Del Toro Runzer
Postdoctoral Scholar, Medical Genetics
BioClaudia Del Toro Runzer is a postdoctoral scholar at Stanford University specializing in gene therapy and regenerative medicine. Her current research focuses on developing gene editing strategies for inherited disorders, including GNE myopathy and Gaucher disease. She works on advancing precision gene engineering approaches in human hematopoietic stem and progenitor cells and other clinically relevant cell types, with the goal of enabling safe and durable therapeutic correction.
Dr. Del Toro Runzer earned her PhD in Tissue Engineering from the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University. Her doctoral research focused on chemically modified mRNA therapeutics for bone regeneration, where she investigated molecular design, intracellular trafficking, and biomaterial-assisted delivery systems to enhance protein expression and osteogenic outcomes. Her work resulted in multiple first-author publications in leading journals, including Advanced Functional Materials, Bone Research, Materials Today, and Molecular Therapy: Nucleic Acids.
Prior to her PhD, she completed an M.Sc. in Regenerative Biology and Medicine at Technische Universität Dresden and a B.Sc. in Biotechnology Engineering at Instituto Tecnológico de Monterrey. Her international training spans Germany, the Netherlands, Mexico, and the United States, with research experience in organoid systems, tissue regeneration, biomaterials engineering, and microphysiological platforms. -
Erlynn Dela Cruz
Administrative Associate, Pediatrics - Endocrinology
Current Role at StanfordAdministrative Associate
